These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Dubinsky RM. Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516 [No Abstract] [Full Text] [Related]
3. Effects of botulinum toxin A on calf muscles in children with cerebral palsy: a systematic review. Koog YH, Min BI. Clin Rehabil; 2010 Aug; 24(8):685-700. PubMed ID: 20554641 [Abstract] [Full Text] [Related]
6. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A]. Madsen ES, Sonne-Holm S, Wong C, Curtis D, Bencke J. Ugeskr Laeger; 2015 Jan 12; 177(3):V07140409. PubMed ID: 25613095 [Abstract] [Full Text] [Related]
11. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity. Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ. Am J Phys Med Rehabil; 2003 Apr 12; 82(4):284-9. PubMed ID: 12649654 [Abstract] [Full Text] [Related]
13. Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review. Mathevon L, Declemy A, Laffont I, Perennou D. Ann Phys Rehabil Med; 2019 Jul 12; 62(4):241-251. PubMed ID: 30980953 [Abstract] [Full Text] [Related]
14. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy? Barrett RS. Dev Med Child Neurol; 2011 Jun 12; 53(6):485. PubMed ID: 21518344 [No Abstract] [Full Text] [Related]